Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

72.60
Delayed Data
As of Sep 23
 -1.45 / -1.96%
Today’s Change
46.52
Today|||52-Week Range
117.12
-35.28%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close74.05
Today’s open74.34
Day’s range72.50 - 75.31
Volume511,138
Average volume (3 months)679,445
Market cap$2.9B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-76.00%
Earnings growth (this year)-50.64%
Earnings growth (next 5 years)+25.28%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.32

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-1.05-2.53%
SRPTSarepta Therapeutics...-3.14-5.15%
GWPHGW Pharmaceuticals P...-2.20-2.00%
HZNPHorizon Pharma PLC+0.02+0.10%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$1.53
Annual revenue (last year)$0.00
Annual profit (last year)-$145.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

Search for Jobs